Central Nervous System
If you don't find a topic or disease in our list of publications, please call (toll free in the U.S.): +1-866-296-8352 or email us so that we can guide you to related or upcoming coverage or discuss a customized project through our consulting group.
Covering both psychiatric and neurological indications, Decision Resources assesses the overall clinical and commercial environment for central nervous system (CNS) drug therapies to offer organizations an invaluable guide for understanding these markets. Averaging 10 reports per year, Decision Resources offers one of the largest CNS portfolios available from a market research firm.
Upcoming CNS reports:
- Alzheimer’s Disease
- Schizophrenia
- Parkinson’s Disease
- Bipolar
- Multiple Sclerosis
- Stroke
- Major Depression
Round-up
Register to receive Decision Resources' round-up, a summary email of the company's latest research, products, and special offers.
Decision Resources Group companies include: